These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28922018)

  • 1. Tacrolimus Ointment for Refractory Posterior Blepharitis.
    Sakassegawa-Naves FE; Ricci HMM; Moscovici BK; Miyamoto DA; Chiacchio BB; Holzchuh R; Santo RM; Hida RY
    Curr Eye Res; 2017 Nov; 42(11):1440-1444. PubMed ID: 28922018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
    Sakarya Y; Sakarya R
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FK 506 ointment 0.1 % - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients].
    Mayer K; Reinhard T; Reis A; Böhringer D; Sundmacher R
    Klin Monbl Augenheilkd; 2001 Nov; 218(11):733-6. PubMed ID: 11731901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction.
    Perry HD; Doshi-Carnevale S; Donnenfeld ED; Solomon R; Biser SA; Bloom AH
    Cornea; 2006 Feb; 25(2):171-5. PubMed ID: 16371776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral azithromycin for treatment of posterior blepharitis.
    Igami TZ; Holzchuh R; Osaki TH; Santo RM; Kara-Jose N; Hida RY
    Cornea; 2011 Oct; 30(10):1145-9. PubMed ID: 21849891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.
    Virtanen HM; Reitamo S; Kari M; Kari O
    Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA; Kaufman HE; Insler M
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.
    Corrocher G; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Gelio S; Lombardo G; Pacor ML
    Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis.
    Opitz DL; Tyler KF
    Clin Exp Optom; 2011 Mar; 94(2):200-6. PubMed ID: 21083761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bibrocathol eye ointment is efficacious in blepharitis. Results from a randomized, double-blind, controlled clinical trial].
    Behrens-Baumann W; Niederdellmann C; Jehkul A; Kohnen R
    Ophthalmologe; 2006 Nov; 103(11):960-5. PubMed ID: 17003947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of topical azithromycin therapy in patients with blepharitis and meibomian gland dysfunction.
    Shimazaki J; Kito G; Kamoi M; Satake Y
    Jpn J Ophthalmol; 2024 Sep; 68(5):472-481. PubMed ID: 39002075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.
    Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG
    Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases.
    Lee YJ; Kim SW; Seo KY
    Am J Ophthalmol; 2013 May; 155(5):804-13. PubMed ID: 23394907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy.
    Matsumoto Y; Shigeno Y; Sato EA; Ibrahim OM; Saiki M; Negishi K; Ogawa Y; Dogru M; Tsubota K
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):821-9. PubMed ID: 19101718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction.
    Arita R; Kawashima M; Ito M; Tsubota K
    BMC Ophthalmol; 2017 Jun; 17(1):84. PubMed ID: 28592257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressure.
    Remitz A; Virtanen HM; Reitamo S; Kari O
    Acta Ophthalmol; 2011 May; 89(3):e295-6. PubMed ID: 20064110
    [No Abstract]   [Full Text] [Related]  

  • 17. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
    Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
    Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.